Inflammation Drugs Flashcards
1
Q
- abatacept
- T-cell inhibitor
- RA, PsA, JIA
- maltose in IV formulation
- may exacerbate COPD
A
Orencia
2
Q
- natalizumab
- Selective Adhesion-Molecule Inhibitor
- CD
- REMS=CD-Touch for PML risk
- BBW for PML
A
Tysabri
3
Q
- ixekizumab
- IL-17a inhibitor
- AS, PsA, PP, nr-axSpA
- may trigger IBD
A
Taltz
4
Q
- infliximab
- TNF inhibitor
- RA w/methotrexate, CD, UC, PsA, PP, AS
A
Remicade
5
Q
- certolizumab pegol
- TNF inhibitor
- Subq
- RA, AS, nr-axSpA, PsA, PP, CD
- latex free
A
-Cimzia
6
Q
- dupilumab
- IL-4 inhibitor
- AD, off-label for asthma
- ocular SEs
A
Dupixent
7
Q
- upadacitinib
- JAK inhibitor
- RA
- SE: diverticulitis
- BBW: serious infections, malignancy
A
Rinvoq
8
Q
- guselkumab
- IL-23 inhibitor
- PsA, PP
- supplied as PFS or One-Press Patient Controlled Injector device
- latex free
A
Tremfya
9
Q
- ustekinumab
- IL 12/23 inhibitor
- PP, PsA, CD, UC
- latex in needle cover and guard
- SE of posterior leukoencephalopathy syndrome and squamous cell carcinoma
- BCG vaccine at least 1yr apart
A
Stelara
10
Q
- baracitinib
- JAK inhibitor
- RA
- SE: diverticulitis
- BBW: thrombosis, serious infections, malignancy
A
Olumiant
11
Q
- etanercept
- TNF inhibitor
- RA, AS, PsA, PP, pJIA, ped PP
- supplied as vial, PFS, Sureclick and mini w/auto touch
A
Enbrel
12
Q
- teduglutide
- GLP-2 Analog
- subq
- Short Bowel Syndrome
- monitor fluid status with CVD pts
- REMS: increase awareness of noeplastic growth, colon polyp growth, GI obstruction, and biliary/pancreatic disorders
A
Gattex
13
Q
- tofacitinib
- JAK inhibitor
- RA, PsA, UC
- SE: diverticulitis
- BBW: serious infection, malignancy
- XR: inert tablet shell in the stool
A
Xeljanz
14
Q
- tocilizumab
- IL-6 inhibitor
- subq and IV
- RA, pJIA, sJIA (IV), GCA (subQ)
- monitor for s/s of demyelination & GI perforation
A
Actemra
15
Q
- Rilonacept
- IL-1 inhibitor
- CAPS
- reconstitution stable at RT < 3 hours
A
Arcalyst